Tranzyme Pharma Announces First Quarter 2012 Financial Results 
MarketWatch (press release)
"We are very pleased that patient enrollment in our 12-week Phase 2b trial evaluating TZP-102 for diabetic gastroparesis is moving ahead according to plan and we are on target to complete this trial in the second half of this year and announce top-line ...

and more » 

Tranzyme Pharma Announces First Quarter 2012 Financial Results 
NCTechNews (press release)
?We are very pleased that patient enrollment in our 12-week Phase 2b trial evaluating TZP-102 for diabetic gastroparesis is moving ahead according to plan and we are on target to complete this trial in the second half of this year and announce top-line ...

and more » 

Gastroparesis and Diabetes 
About - News & Issues
By Elizabeth Woolley, About.com GuideApril 28, 2012 Up to 50% of people with type 2 diabetes can suffer from gastroparesis. Wait. There is a better way to say that. They may have gastroparesis and not necessarily suffer because oftentimes the symptoms ...

and more » 

It's Complicated 
Manila Bulletin
By MALOU E. ROSAL MANILA, Philippines ? If you're a diabetic, you've probably heard it said that no one actually dies of diabetes itself. Instead, patients can succumb due to the complications that arise from this dreaded disease.

 

A new and cherished life 
Victorville Daily Press
?Even beyond the diabetes, she was a fighter.? In 2000, Woltil was fitted with a chest catheter and a feeding tube after she was diagnosed with gastroparesis, a condition that prevented her stomach from working properly. Woltil moved home from college ...

 

Tranzyme Pharma to Report First Quarter 2012 Financial Results 
GlobeNewsWire (press release)
Tranzyme's oral ghrelin agonist, TZP-102, targets this significantly underserved market and is currently being evaluated in a Phase 2b trial enrolling patients with chronic diabetic gastroparesis. Top-line data from this trial are expected by the end ...

and more »